Figure 1.

Myricetin inhibits cell viability in ovarian cancer cells. (A) Structure of myricetin. (B) Cells (1×10⁴/well) were seeded in 96-well plates, incubated overnight, and then treated with myricetin for 24 h. Cell viability was determined by an MTT-based method and expressed as percentages of control. (C) Myricetin suppressed OVCAR-3 cells growth in vivo. Chicken chorioallantoic membrane (CAM) assay shows tumor without myricetin treatment, and treated with 20 μM myricetin. After 5 days of treatment, the tumors were excised. Weight of xenografted tumor implanted on CAM treated with and without myricetin (0 and 20 μM). ^*p<0.05 as compared to control.